Browsing: Nordisks
Amgen stock gains on drug results of Novo Nordisk. Novo Nordisk’s CagriSema drug reduced testings subjects’ weight less than expected.…
By Andrew Silver SHANGHAI (Reuters) – Novo Nordisk (NYSE:)’s hugely popular weight-loss drug Wegovy has been approved in China, it…
The blockbuster diabetes drug Ozempic could be manufactured for less than $5 a month, even as Novo Nordisk charges close…
© 2024 American CEO Club. All Rights Reserved.